OSI has backed digital wellness technology company BioBeats, which was founded by University of Surrey faculty and counts multiple corporates among its shareholders.
BioBeats, a UK-based digital wellness technology company co-founded by University of Surrey faculty, closed a £2.4m ($3m) round led by university venture fund Oxford Sciences Innovation (OSI) on Tuesday.
The round also included investment firm White Cloud Capital and VC firm IQ Capital.
Founded in 2012, BioBeats is developing digital products that apply artificial intelligence to data collected from wearable devices to help monitor and improve human wellbeing.
Its flagship product is a mobile app-accessible course on controlling occupational stress called BioBase, piloted in 2015 in partnership with insurance firm Axa and banking group BNP Paribas.
The capital will support BioBeats’ efforts to secure custom for BioBase globally.
BioBeats was founded by chief science officer David Plans, a lecturer in entrepreneurship and innovation at Surrey whose focus includes using media algorithms in healthcare, and chief technology officer Davide Morelli, research fellow at Surrey.
The pair were helped by entrepreneur Nadeem…
